Vancouver, Canada

Lloyd B Jeffs

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 4.0

ph-index = 14

Forward Citations = 1,416(Granted Patents)


Location History:

  • Burnaby, CA (2012 - 2016)
  • Delta, CA (2011 - 2021)
  • Vancouver, CA (2022 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Lloyd B. Jeffs: Innovator in Nucleic Acid Delivery Systems**

Introduction

Lloyd B. Jeffs is a prominent inventor based in Vancouver, CA, known for his innovative contributions to the field of biotherapeutics. With an impressive portfolio of 18 patents, Jeffs has made significant strides in the development of non-liposomal systems for nucleic acid delivery, pushing the boundaries of therapeutics for various medical applications.

Latest Patents

Jeffs' latest patents focus on the creation of novel, stable lipid particles that possess a non-lamellar structure. These lipid particles are designed to include one or more active therapeutic agents. Specifically, his inventions include stable nucleic acid-lipid particles (SNALP) that can incorporate nucleic acids, such as interfering RNA. The patents outline methods for the fabrication of these lipid particles as well as strategies for their delivery and administration. This groundbreaking work has the potential to revolutionize the way therapeutics are developed and applied in medicine.

Career Highlights

Throughout his career, Jeffs has been associated with notable companies in the biotechnology sector, including Protiva Biotherapeutics, Inc. and Arbutus Biopharma Corporation. His experiences in these organizations have undoubtedly contributed to his expertise in biotherapeutic innovations.

Collaborations

In his professional journey, Jeffs has collaborated with distinguished colleagues such as Lorne Ralph Palmer and Ian MacLachlan. These collaborations have fostered an environment of innovation, enabling the development of cutting-edge solutions in the area of nucleic acid delivery systems.

Conclusion

Lloyd B. Jeffs stands out as a key figure in the advancement of therapeutic technologies. With a robust patent portfolio and valuable collaborations under his belt, his work continues to have a lasting impact on the field of biotherapeutics, paving the way for new treatment methodologies that could improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…